FADOI survey on chronic kidney disease and anaemia in internal medicine departments of Italian hospitals

Published: 29 May 2023
Abstract Views: 1096
PDF: 358
HTML: 11
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The presence of anaemia in patients with chronic kidney disease (CKD) is associated with decreased quality of life, along with increased morbidity, mortality, and hospitalization rates. This, in turn, affects healthcare costs and the utilization of medical resources. The mechanisms involved in anaemia of CKD are diverse and complex. They include reduced production of endogenous erythropoietin (EPO), absolute and/or functional iron deficiency (due to inflammation leading to elevated levels of hepcidin), the diminished response of the bone marrow to EPO due to uraemic toxins, the shortened lifespan of red blood cells (RBC), and deficiencies in vitamin B12 or folic acid. [...]

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

PlumX Metrics

PlumX Metrics  provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

Citations

Fishbane S, Spinowitz B. Update on anaemia in ESRD and earlier stages of CKD: core curriculum 2018. Am J Kidney Dis 2018;71:423-35. DOI: https://doi.org/10.1053/j.ajkd.2017.09.026
Nakanishi T, Kimura T, Kuragano T. The Hepcidin-Anemia Axis: Pathogenesis of Anemia in Chronic Kidney Disease. Contrib Nephrol 2019;198:124-34. DOI: https://doi.org/10.1159/000496636
Montagnani A, Frasson S, Gussoni G, et al. Anemia and iron in internal medicine: an Italian survey and a review on iron intravenous therapy in medical patients. Ital J Med 2022;16:1-9. DOI: https://doi.org/10.4081/itjm.2022.1532
Takkavatakarn K, Thammathiwat T, Phannajit J, et al.The impacts of hypoxia-inducible factor stabilizers on laboratory parameters and clinical outcomes in chronic kidney disease patients with renal anemia: a systematic review and meta-analysis. Clin Kidney J 2023;16:845-58. DOI: https://doi.org/10.1093/ckj/sfac271

How to Cite

Bocchi, P., Montagnani, A., Meschi, M., Pomero, F., Piccolo, P., Valerio, A., Gussoni, G., Manfellotto, D., Dentali, F., & in Internal Medicine (CKD-AIM) FADOI Study Group, C. K. D. and A. (2023). FADOI survey on chronic kidney disease and anaemia in internal medicine departments of Italian hospitals. Italian Journal of Medicine, 17(1). https://doi.org/10.4081/itjm.2023.1605